Rosalind Advisors, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001622627

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 34 positions · Total reported value $205.64M · Top-10 concentration 63.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 9 new · 11 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.7% · vs SPY +2.5% · Prev Value $269.06M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.8% · vs SPY -7.9% · Latest Value $244.66M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Rosalind Advisors, Inc. disclosed 34 equity positions with a combined reported value of $205.64M. The filing implies a focused portfolio: its ten largest positions account for 63.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were DCTH ($29.00M), VSTM ($15.95M), XERS ($13.70M). By sector, the heaviest allocations are Health Care 92.4%, Materials 0.3%. Versus the prior quarter, allocation shifted toward Health Care (+9.2pp) and away from Materials (-0.5pp), Other (-8.6pp).

Versus the prior quarter, Rosalind Advisors, Inc. opened 9 new positions, trimmed 11 and fully exited 3, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q1 2025 were IDYA ($11.47M), VRDN ($8.02M), NUVB ($4.31M).

Of the 3 positions fully exited versus the prior quarter, the largest were CMRX ($10.61M), CVSI ($3.65M), BMEA ($2.76M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • IDYA IDEAYA BIOSCIENCES INC · $11.47M
  • VRDN VIRIDIAN THERAPEUTICS INC · $8.02M
  • NUVB NUVATION BIO INC · $4.31M
  • PHVS PHARVARIS N V · $3.51M
  • MNMD MIND MEDICINE MINDMED INC · $2.46M
  • COGT COGENT BIOSCIENCES INC · $1.49M
  • KURA KURA ONCOLOGY INC · $660.00K

Fully Exited (vs previous quarter)

  • CMRX CHIMERIX INC · prev qtr: $10.61M
  • CVSI CASSAVA SCIENCES INC · prev qtr: $3.65M
  • BMEA BIOMEA FUSION INC · prev qtr: $2.76M
  • FLNA FILANA THERAPEUTICS INC · prev qtr: $985.06K
  • CRMD CORMEDIX INC · prev qtr: $919.50K
  • EWTX EDGEWISE THERAPEUTICS INC · prev qtr: $807.50K
  • NMRA NEUMORA THERAPEUTICS INC. · prev qtr: $300.24K
  • OWLT OWLET INC · prev qtr: $220.01K

Insider Transactions (Form 4)

Latest Rosalind Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-13 J DELCATH SYSTEMS, INC. 27,502 — SEC filing
2026-10-13 Conversion DELCATH SYSTEMS, INC. 3,627 — SEC filing

All insider transactions →

Fund Profile

Rosalind Advisors, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 33 US equity positions with a combined value of $269.06M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $269.06M reported value (Q2 2026)
  • Top 10 holdings = 74.1% of reported value
  • Largest position: DCTH (DELCATH SYS INC) at 15.4%
  • Average position size: $8.15M

Sector Tilt

  • Health Care 94.7%
  • Industrials 5.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 7 added, 12 reduced, 8 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.4%
Materials 0.3%
Other 7.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.90M $29.00M 14.10%
14.10%
Add
2 2.64M $15.95M 7.75%
7.75%
Add
3 2.50M $13.70M 6.66%
6.66%
Reduce
4 2.70M $13.00M 6.32%
6.32%
Reduce
5 700.00K $11.47M 5.58%
5.58%
New
6 1.78M $10.86M 5.28%
5.28%
Add
7 950.00K $10.51M 5.11%
5.11%
Add
8 1.22M $8.93M 4.34%
4.34%
Add
9 1.81M $8.60M 4.18%
4.18%
Hold
10 850.00K $8.29M 4.03%
4.03%
Add
11 595.00K $8.02M 3.90%
3.90%
New
12 506.89K $7.87M 3.83%
3.83%
Reduce
13 2.65M $7.35M 3.58%
3.58%
Hold
14 100.00K $6.35M 3.09%
3.09%
Reduce
15 2.27M $6.12M 2.98%
2.98%
Reduce
16 810.92K $5.14M 2.50%
2.50%
Hold
17 2.45M $4.31M 2.10%
2.10%
New
18 692.18K $4.03M 1.96%
1.96%
Hold
19 612.90K $3.86M 1.88%
1.88%
Reduce
20 223.63K $3.51M 1.71%
1.71%
New
21 303.86K $3.51M 1.71%
1.71%
Hold
22 1.02M $2.76M 1.34%
1.34%
Hold
23 420.00K $2.46M 1.20%
1.20%
New
24 823.29K $2.35M 1.15%
1.15%
Add
25 256.19K $2.35M 1.14%
1.14%
Reduce
26 248.28K $1.49M 0.72%
0.72%
New
27 2.00M $991.95K 0.48%
0.48%
Add
28 250.06K $752.68K 0.37%
0.37%
Hold
29 100.00K $660.00K 0.32%
0.32%
New
30 104.84K $530.47K 0.26%
0.26%
Reduce
31 644.39K $515.51K 0.25%
0.25%
Reduce
32 50.00K $373.50K 0.18%
0.18%
Reduce
33 1.28M $30.00K 0.01%
0.01%
Hold
34 15.80K $3.57K 0.00%
0.00%
Reduce

FAQ

What did Rosalind Advisors, Inc. buy in 2025-Q1?

In its 2025-Q1 13F filing, Rosalind Advisors, Inc. reported 34 equity positions worth $205.64M in aggregate; its largest disclosed positions were DCTH ($29.00M), VSTM ($15.95M), XERS ($13.70M).

How large is Rosalind Advisors, Inc.'s portfolio?

Rosalind Advisors, Inc. reported $205.64M of long equity holdings across 34 positions as of 2025-Q1. Top-10 holdings account for 63.4% of reported value.

What is Rosalind Advisors, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rosalind-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →